Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations

Regimens that could treat both rifampin-resistant (RR) and rifampin-susceptible tuberculosis (TB) while shortening the treatment duration have reached late-stage clinical trials. Decisions about whether and ho...

Source: BMC Infectious Diseases - September 9, 2019 Category: Infectious Diseases Authors: Emily A. Kendall, Shelly Malhotra, Sarah Cook-Scalise, Claudia M. Denkinger and David W. Dowdy Tags: Research article Source Type: research